FOGHORN THERAPEUTICS INC. Item 5.07 Submission of Matters to a Vote of Security Holders.
On
(i) To elect
(ii) To ratify the selection of
The proposals are described in detail in the Company's Proxy Statement filed
with the
The number of shares of common stock entitled to vote at the Annual Meeting was 36,846,084. The number of shares of common stock present or represented by valid proxy at the Annual Meeting was 28,665,401.97. All matters submitted to a vote of the Company's stockholders at the Annual Meeting were approved and all director nominees were elected.
The number of votes cast for and against and the number of abstentions and broker non-votes with respect to each matter voted upon are set forth below:
(i) Election of directors. Director Nominee Votes For Votes Against Abstentions Scott Biller, Ph.D. 25,605,357.97 1,080,818.00 8,277.00 Cigall Kadoch, Ph.D. 25,474,272.98 1,211,902.99 8,277.00 Michael Mendelsohn, M.D. 25,531,488.99 1,154,685.00 8,278.98
There were 1,970,949 broker non-votes regarding the election of directors.
(ii) Ratification of selection of independent registered public accounting firm.
Stockholders ratified the selection of
--------------------------------------------------------------------------------
© Edgar Online, source
